Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM)

Tissue Antigens

Volumn 47, Issue 1, 1996, Pages 37-48

  Yasunaga, S ^a   Kimura, A ^a   Hamaguchi, K ^b   Ronningen K S ^c   Sasazuki, T ^a,d  

^a KYUSHU UNIVERSITY   (Japan)

^b OITA UNIVERSITY   (Japan)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Based oligotyping; Disease susceptibility; HLA DQ; HLA DR; Insulin dependent diabetes mellitus (IDDM); Linkage disequilibrium; Polymerase chain reaction (PCR); Polymorphism; Sequence specific oligonucleotide probe (SSOP)

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN;

ALLELE; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOBLASTOID CELL; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 0030070997     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02512.x     Document Type: Article

References (83)

1. Hirayama K, Matsushita S, Kikuchi I, Iuchi M, Ohta M, Sasazuki T. HLA-DQ is epistatic to HLA-DR in controlling the immune response to shistosomal antigen in humans. Nature 1987: 327: 426-430.
2. Sasazuki T, Kikuchi I, Hirayama K, Matsushita S, Ohta N, Nishimura Y. HLA-linked immune suppression in humans. Immunology 1989: suppl 2: 21-29.
3. Altmann DM, Dansom SD, Marsh SGE. What is the basis for HLA-DQ associations with autoimmune disease? Immunol Today 1991: 12: 267-270.
4. Todd JA, Acha-Orbea H, Bell JI et al. A molecular basis for MHC class II- associated autoimmunity. Science 1988: 240: 1003-1009.
5. Nishimura Y, Thorsby E, Rønningen KS et al. General organization and overview of the disease component. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol. 1. Oxford: Oxford University Press, 1992: 693-700.
6. Hattori M, Buse JB, Jackson RA et al. The NOD mouse: Recessive diabetogenic gene in major histocompatibility complex. Science 1986: 231: 733-735.
7. Holmdahl R, Jansson L, Andersson M, Larsson E. Immunogenetics of type II collagen arthritis. Immunology 1988: 65: 305-310.
8. Gepts W. The pathology of the pancreas in human diabetes. In: Andreani D, DiMario V, Federlin KF, Heding LG, ed. Immunology in diabetes. London: Kimptom, 1984: 21-34.
9. Eisenbarth GS. Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 1986: 314: 1360-1368.
10. Svejgaad A, Platz P, Ryder LP. Joint report: Insulin-dependent diabetes mellitus. In: Terasaki P, ed. Histocompatibility testing 1980. Los Angeles: UCLA Tissue Typing Laboratory, 1980: 638-656.
11. Svejgaad A, Platz P, Ryder LP. HLA and disease 1982 a survey. Immunol Rev 1983: 70: 193-218.
12. Bertrams J, Baur MP. Disease report: insulin-dependent diabetes mellitus. In: Albert E, Baur M, Mayr W, ed. Histocompatibility testing 1984. Berlin: Springer-Verlag, 1984: 348-358.
13. Thomson G. HLA DR antigens and susceptibility to insulin-dependent diabetes mellitus. Am J Hum Genet 1984: 36: 1309-1317.
14. Tiwari JL, Terasaki PI. Juvenile diabetes mellitus (insulin-dependent). In: Tiwari JL, Terasaki PI, ed. HLA and disease associations. New York: Springer-Verlag, 1985: 185-210.
15. Thomson G, Robinson WP, Kuhner MK et al. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am J Hum Genet 1988: 43: 799-816.
16. Owerbach D, Lernmark Å, Platz P et al. HLA-D region β-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetec individuals. Nature 1983: 303: 815-817.
17. Arnheim N, Strange C, Erlich H. Use of pooled DNA samples to detect linkage disequilibrium of polymorphic restriction fragments and human disease: studies of the HLA class II loci. Proc Natl Acad Sci U S A 1985: 82: 6970-6974.
18. Cohen-Haguenauer O, Robbins E, Massart C et al. A systematic study of HLA class II-β DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 1985: 82: 3335-3339.
19. Böhme J, Carlsson B, Wallin J et al. Only one DQ-β restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes. J Immunol 1986: 137: 941-947.
20. Festenstein H, Awad J, Hitman GA et al. New HLA DNA polymorphisms associated with autoimmune diseases. Nature 1986: 322: 64-67.
21. Nepom BS, Palmer J, Kim SJ, Hansen JA, Holbeck SL, Nepom GT. Specific genomic markers for the HLA-DQ subregion discriminate between DR4+ insulin-dependent diabetes mellitus and DR4+ seropositive juvenile rheumatoid arthritis. J Exp Med 1986: 164: 345-350.
22. Schreuder GMT, Tilanus GJ, Bontrop RE et al. HLA-DQ polymorphism associated with resistance to type I diabetes detected with monoclonal antibodies, isoelectric point differences, and restriction fragment length polymorphism. J Exp Med 1986: 164: 938-943.
23. Tait BD, Boyle AL. DR4 and susceptibility to type I diabetes mellitus: Discrimination of high risk and low risk DR4 haplotypes on the basis of TA10 typing. Tissue Antigens 1986: 28: 65-71.
24. Todd JA, Bell JI, McDevitt HO. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987: 329: 599-604.
25. Horn GT, Bugawan TL, Long CM, Erlich HA. Allelic sequence variation of the HLA-DQ loci: Relationship to serology and to insulin-dependent diabetes susceptibility. Proc Natl Acad Sci U S A 1988: 85: 6012-6016.
26. Morel PA, Dorman JS, Todd JA, McDevitt HO, Trucco M. Aspartic acid at position 57 of the HLA-DQβ chain protects against type I diabetes: A family study. Proc Natl Acad Sci U S A 1988: 85: 8111-8115.
27. Khalil I, d'Auriol L, Gobet M et al. A combination of HLA-DQβ Asp57-negative and HLA DQα Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 1990: 85: 1315-1319.
28. Khalil I, Deschamps I, Lepage V, Al-Daccak R, Degos L, Hors J. Dose effect of cis and trans-encoded HLA-DQαβ heterodimers in IDDM susceptibility. Diabetes 1992: 41: 378-384.
29. Aparicio JMR, Wakisaka A, Takada A, Matsuura N, Aizawa M. HLA-DQ system and insulin-dependent diabetes mellitus in Japanese: does it contribute to the development of IDDM as it does in Caucasians? Immunogenetics 1988: 28: 240-246.
30. Lundin KEA, Rønningen KS, Aono S et al. HLA-DQ antigens and DQβ amino acid 57 of Japanese patient with insulin-dependent diabetes mellitus: detection of a DRw8DQw8 haplotype. Tissue Antigens 1989: 34: 233-241.
31. Awata T, Kuzuya T, Matsuda A et al. High frequency of aspartic acid at position 57 of HLA-DQ β-chain in Japanese IDDM patients and nondiabetic subjects. Diabetes 1990: 39: 266-269.
32. Todd JA, Fukui Y, Kitagawa T, Sasazuki T. The A3 allele of the HLA-DQA1 locus is associated with susceptibility to type 1 diabetes in Japanese. Proc Natl Acad Sci U S A 1990: 87: 1094-1098.
33. Yamagata Y, Hanafusa T, Nakajima H et al. HLA DQA1* 1 contributes to resistance and A1*3 confers susceptibility to type 1 (insulin-dependent) diabetes mellitus in Japanese subjects. Diabetologia 1991: 34: 133-136.
34. Jacobs KH, Jenkins D, Mijovic C et al. An investigation of Japanese subjects maps susceptibility to type 1 (insulin-dependent) diabetes mellitus close to the DQA1 gene. Hum Immunol 1992: 33: 24-28.
35. Rønningen KS, Spurkland A, Tait BD et al. HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids, and Japanese. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol. 1. Oxford: Oxford University Press, 1992: 713-722.
36. Penny MA, Mijovic CH, Cavan DA et al. An investigation of the association between HLA-DQ heterodimers and type 1 (insulin-dependent) diabetes mellitus in five racial groups. Hum Immunol 1993: 38: 179-183.
37. Bao M, Wang J, Dorman JS, Trucco M. HLA-DQ non-asp-57 allele and incidence of diabetes in China and the USA. Lancet 1989: ii: 497-498.
38. Ju LY, Sun YP, Semana G et al. Aspartic acid at position 57 of the HLA-DQβ chain in insulin-dependent diabetes mellitus: an association with one DRw9-DQw9 subtype in the Chinese population. Tissue Antigens 1991: 37: 218-223.
39. Penny MA, Jenkins D, Mijovic CH et al. Susceptibility to IDDM in a Chinese population. Diabetes 1991: 41: 914-919.
40. Hu CY, Allen M, Chuang LM, Lin BJ, Gyllensten U. Association of insulin-dependent diabetes mellitus in Taiwan with HLA class II DQB1 and DRB1 alleles. Hum Immunol 1993: 38: 105-114.
41. Fernandez-Vinā M, Ramirez LC, Raskin P, Stastny P. Genes for insulin-dependent diabetes mellitus (IDDM) in the major histocompatibility complex (MHC) of African-Americans. Tissue Antigens 1993: 41: 57-64.
42. Khalil I, Spyropoulou M, Mallet C et al. HLA class II polymorphism and IDDM susceptibility in the Greek population. Eur J Immunogenet 1993: 20: 193-199.
43. Erlich HA, Zeidler A, Chang J et al. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus on Mexican-American families. Nature Genet 1993: 3: 358-364.
44. Kockum I, Wassmuth R, Holmberg E, Michelsen B, Lernmark Å. HLA-DQ primarily confers protection and HLA-DR susceptibility in type I (insulin-dependent) diabetes studied in population-based affected families and controls. Am J Hum Genet 1993: 53: 150-167.
45. Marsh SGE, Bodmer JG. HLA class II nucleotide sequences, 1992. Immunogenetics 1993: 37: 79-94.
46. Kimura A, Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA DNA-typing technique. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991: Proceedings of the Eleventh International Workshop and Conference. Vol. 1. Oxford: Oxford University Press, 1992: 397-419.
47. Kimura A, Dong RP, Harada H, Sasazuki T. DNA typing of HLA class II genes in B-lymphoblastoid cell lines homozygous for HLA. Tissue Antigens 1992: 40: 5-12.
48. Yang SY, Milford E, Hammerling U, Dupont B. Description of the reference panel of B-lymphoblastoid cell lines for factors of the HLA system: The B-cell line panel designed for the Tenth International Histocompatibility Workshop. In: Dupont B. ed. Immunology of HLA. Vol. 1. Histocompatibility testing. New York: Springer-Verlag, 1989: 11-19.
49. Scherrer K. Isolation and sucrose gradient analysis of RNA. In: Habel K, Salzman NP, ed. Fundamental techniques in virology. New York: Academic Press, 1969: 413-432.
50. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977: 74: 5463-5467.
51. Imanishhi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T, ed. HLA 1991: Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Vol. 1. Oxford: Oxford University Press, 1992: 1065-1220.
52. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet 1955: 19: 251-253.
53. Miettinen O. Estimability and estimation in case-referent studies. Am J Epidemiol 1976: 103: 226-235.
54. Svejgaad A, Ryder LP. HLA-genotype distribution and genomic models of insulin-dependent diabetes mellitus. Ann Hum Genet 1981: 45: 293-298.
55. Haldane S. The estimation and significance of the logarithm of a ratio of frequencies. Ann Hum Genet 1956: 20: 309-311.
56. Bodmer JG, Marsh SGE, Albert ED et al. Nomenclature for factors of the HLA system, 1995. Tissue Antigens 1995: 46: 1-18.
57. Lee KW, Johnson AH, Hurley CK. New DQw1 diversity identified within DRw12 and DRw14 haplotypes. Tissue Antigens 1991: 38: 231-234.
58. Auffray C, Lillie JW, Arnot D, Grossberger D, Kappes D, Strominger JL. Isotypic and allotypic variation of human class II histocompatibility antigen α-chain genes. Nature 1984: 308: 327-333.
59. Moriuchi J, Moriuchi T, Silveer J. Nucleotide sequence of HLA-DQ a chain derived from a DRw9 cell line: genetic and evolutionary implications. Proc Natl Acad Sci U S A 1985: 82: 3420-3424.
60. Bell JI, Todd JA, McDevitt HO. The molecular basis of HLA-disease association. Adv Hum Genet 1989: 18: 1-41.
61. Liu CP, Bach FH, Wu S. Molecular study of a rare DR2/LD-5a/DQw3 HLA class II haplotype: multiple genetic mechanisms in the generation of polymorphic HLA class II genes. J Immunol 1988: 140: 3631-3639.
62. Hall MA, Lanchbury JS, Lee JS, Welsh KI, Ciclitira PJ. HLA-DQ2 second-domain polymorphisms may explain increased trans-associated risk in celiac disease and dermatitis herpetiformis. Hum Immunol 1993: 38: 284-292.
63. Briata P, Radka SF, Sartoris S, Lee JS. Alternative splicing of HLA-DQB transcripts and secretion of HLA-DQ β-chain proteins: allelic polymorphism in splicing and polyadenylation sites. Proc Natl Acad Sci U S A 1989: 86: 1003-1007.
64. Fogdell A, Olerup O. The DQA1*0104 allele is carried by DRB1*1001- and DRB1*1401- positive haplotypes in Caucasians, Africans and Orientals. Tissue Antigens 1994: 44: 19-24.
65. Fernandez-Vinā MA, Falco M, Gao X et al. DQA 1*03 subtypes have different associations with DRB1 and DQB1 alleles. Hum Immunol 1994: 39: 290-298.
66. Sheehy MJ, Rowe JR, MacDonald MJ. A particular subset of HLA-DR4 accounts for all or most of the DR4 association in type I diabetes. Diabetes 1985: 34: 942-944.
67. Monos DS, Mickelson E, Hansen JA, Baker L, Zmijewski CM, Kamoun M. Analysis of DR and DQ gene products of the DR4 haplotype in patients with IDDM: Possible involvement of more than one locus. Hum Immunol 1988: 23: 289-299.
68. Rowe JR, Mickelson EM, Hansen et al. T-cell-delined DR4 subtypes as markers for type 1 diabetes. Hum Immunol 1988: 22: 51-60.
69. Sheeny MJ, Scharf SJ, Rowe JR. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J Clin Invest 1989: 83: 830-835.
70. Erlich HA, Bugawan TL, Scharf S, Nepom GT, Tait B, Griffith RL. HLA-DQβ sequence polymorphism and genetic susceptibility to IDDM. Diabetes 1990: 39: 96-103.
71. Garcia-Pacheco JM, Herbut B, Cutbush S et al. Distributions of HLA-DQA1, -DQB1 and DRB1 alleles in black IDDM patients and controls from Zimbabwe. Tissue Amigens 1992: 40: 145-149.
72. Caillat-Zucman S, Garchon H-J, Timsit J et al. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J Clin Invest 1992: 90: 2242-2250.
73. Cucca F, Muntoni F, Lampis R et al. Combinations of specific DRB1, DQA1, DQB1 haplotypes are associated with insulin-dependent diabetes mellitus in Sardinia. Hum Immunol 1993: 37: 85-94.
74. Rønningen KS, Gjertsen HA, Iwe T, Spurkland A, Hansen T, Thorsby E. Particular HLA-DQ αβ heterodimer associated with IDDM susceptibility in both DR4-DQw4 Japanese and DR4-DQw8 DRw8-DQw4 Whites. Diabetes 1991: 40: 759-763.
75. Rønningen KS, Spurkland A, Iwe T, Vartdal F, Thorsby E. Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens 1991: 37: 105-111.
76. Thorsby E, Rønningen KS. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993: 36: 371-377.
77. Cammarota G, Scheirle A, Takacs et al. Identification of CD4 binding site on the β2 domain of HLA-DR molecules. Nature 1992: 356: 799-801.
78. Brown JH, Jardetzky TS, Gorga JC et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993: 364: 33-39.
79. Todd JA, Mijovic CH, Fletcher JA, Jenkins D, Bradwell AR, Burnett AH. Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature 1989: 338: 587-589.
80. Mijovic CH, Jenkins D, Jacobs KH, Penny MA. Fletcher JA Barnett AH. HLA-DQA1 and -DQB1 alleles associated with genetic susceptibility to IDDM in a Black population. Diabetes 1990: 40: 748-753.
81. Cavan DA, Jacobs KH, Penny MA et al. Both DQA1 and DQB1 genes are implicated in HLA-associated protection from Type 1 (insulin-dependent) diabetes mellitus in a British Caucasian population. Diabetologia 1993: 36: 252-257.
82. Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD. Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 1990: 322: 1836-1841.
83. Sterkers G, Zeliszewski D, Chaussee AM et al. HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes. Proc Natl Acad Sci U S A 1988: 85: 6473-6477.